Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
First Claim
1. A method for in vivo treatment of smooth muscle disorders of a mammal, comprising:
- injecting directly into a smooth muscle in a mammal an amount of a neurotoxin which inhibits neurotransmitter release from nerve terminals.
2 Assignments
0 Petitions
Accused Products
Abstract
Direct injection of sphincteric botulinum toxin is disclosed as an effective, safe and simple method of treatment for disorders of gastrointestinal muscle or smooth muscles elsewhere in the body, with results that appear to be sustained for several months. Muscle disorders which are suitable for such treatment include achalasia, isolated disorders of the lower esophageal sphincter, gastroparesis, hypertrophic pyloric stenosis, sphincter of Oddi dysfunction, short-segment Hirschsprung'"'"'s, anal fissure, hemorrhoids, proctalgia fugax, irritable bowel syndrome, disorders of the upper esophageal sphincter, vasospastic disorders, and disorders of uterine and bladder spasm. Devices suitable for delivering this therapy are also disclosed.
468 Citations
24 Claims
-
1. A method for in vivo treatment of smooth muscle disorders of a mammal, comprising:
injecting directly into a smooth muscle in a mammal an amount of a neurotoxin which inhibits neurotransmitter release from nerve terminals. - View Dependent Claims (2, 3, 4, 5, 6, 18, 19, 20, 21, 22, 23, 24)
-
7. A method for in vivo treatment of disorders of a gastrointestinal muscle in the enteric nervous system of a mammal, comprising:
injecting directly into a tissue of enteric nervous system in a mammal an amount of a neurotoxin which inhibits neurotransmitter release from nerve terminals. - View Dependent Claims (8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
Specification